Dr Kathryn Williams

BMed(Sci) MBBS (Hons 1), PhD, FRACP
Lecturer
Medicine, Central Clinical School

Telephone 9515 8628

Map

Biographical details

Kathryn is a Lecturer at the University of Sydney and the Unit Coordinator for the Diabetes Management and Advanced Diabetes Management units of study for the Metabolic Health Postgraduate Program. She is also an HVMO at Royal Prince Alfred Hospital and a Clinical Investigator at the Boden Institute. She works as an endocrinologist in private practice and also has a fortnightly diabetes and endocrine clinic at the Aboriginal Medical Service in Redfern. She completed her medical training in 2001 at the University of New South Wales and is now in the latter stages of a PhD relating to type 2 diabetes and non-alcoholic fatty liver disease.

Selected grants

2014

  • A phase 3, randomized, double-blind, placebo-controlled, 26-week multicentre study with a 78-week extension to evaluate the efficacy and safety of ertugliflozin in subjects with type 2 diabetes mellitus and inadequate glycemic control on metformin monother; Williams K, Caterson I; Merck Sharp & Dohme (Australia) Pty Ltd/Clinical Trial Research Agreement.

Selected publications

Download citations: PDF RTF Endnote

Journals

  • Williams, K., Sullivan, D., Veillard, A., O'Brien, R., George, J., Jenkins, A., Young, S., Ehnholm, C., Duffield, A., Twigg, S., Keech, A. (2016). Low alanine aminotransferase levels and higher number of cardiovascular events in people with Type 2 diabetes: analysis of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. Diabetic Medicine, 33(3), 356-364. [More Information]
  • Williams, K., Burns, K., Constantino, M., Shackel, N., Prakoso, E., Wong, J., Wu, T., George, J., McCaughan, G., Twigg, S. (2015). An association of large-fibre peripheral nerve dysfunction with non-invasive measures of liver fibrosis secondary to non-alcoholic fatty liver disease in diabetes. Journal of Diabetes and Its Complications, 29, 1240-1247.
  • Williams, K., Vieira de Ribeiro, A., Prakoso, E., Veillard, A., Shackel, N., Brooks, B., Bu, Y., Cavanagh, E., Raleigh, J., McLennan, S., McCaughan, G., Keane, F., Gorrell, M., Twigg, S., et al (2015). Circulating Dipeptidyl Peptidase-4 Activity Correlates with Measures of Hepatocyte Apoptosis and Fibrosis in NAFLD in Type 2 Diabetes Mellitus and Obesity: A Dual Cohort Cross-Sectional Study. Journal of Diabetes, 7(6), 809-819. [More Information]
  • Williams, K., Vieira de Ribeiro, A., Prakoso, E., Veillard, A., Shackel, N., Bu, Y., Brooks, B., Cavanagh, E., Raleigh, J., McLennan, S., McCaughan, G., Keane, F., Twigg, S., Gorrell, M., et al (2015). Lower serum fibroblast activation protein shows promise in the exclusion of clinically significant liver fibrosis due to non-alcoholic fatty liver disease in diabetes and obesity. Diabetes Research and Clinical Practice, 108(3), 466-472. [More Information]
  • Fuller, N., Caterson, I., Sainsbury, A., Denyer, G., Fong, M., Gerofi, J., Baqleh, K., Williams, K., Lau, N., Markovic, T. (2015). The effect of a high-egg diet on cardiovascular risk factors in people with type 2 diabetes: the Diabetes and Egg (DIABEGG) study-a 3-mo randomized controlled trial. The American Journal of Clinical Nutrition, 101(4), 705-713. [More Information]
  • Fuller, N., Williams, K., Shrestha, R., Ahern, A., Holzapfel, C., Hauner, H., Jebb, S., Caterson, I. (2014). Changes in physical activity during a weight loss intervention and follow-up; a randomized controlled trial. Clinical Obesity, 4(3), 127-135. [More Information]
  • Williams, K., Shackel, N., Gorrell, M., McLennan, S., Twigg, S. (2013). Diabetes and Nonalcoholic Fatty Liver Disease: A Pathogenic Duo. Endocrine Reviews, 34(1), 84-129. [More Information]

2016

  • Williams, K., Sullivan, D., Veillard, A., O'Brien, R., George, J., Jenkins, A., Young, S., Ehnholm, C., Duffield, A., Twigg, S., Keech, A. (2016). Low alanine aminotransferase levels and higher number of cardiovascular events in people with Type 2 diabetes: analysis of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. Diabetic Medicine, 33(3), 356-364. [More Information]

2015

  • Williams, K., Burns, K., Constantino, M., Shackel, N., Prakoso, E., Wong, J., Wu, T., George, J., McCaughan, G., Twigg, S. (2015). An association of large-fibre peripheral nerve dysfunction with non-invasive measures of liver fibrosis secondary to non-alcoholic fatty liver disease in diabetes. Journal of Diabetes and Its Complications, 29, 1240-1247.
  • Williams, K., Vieira de Ribeiro, A., Prakoso, E., Veillard, A., Shackel, N., Brooks, B., Bu, Y., Cavanagh, E., Raleigh, J., McLennan, S., McCaughan, G., Keane, F., Gorrell, M., Twigg, S., et al (2015). Circulating Dipeptidyl Peptidase-4 Activity Correlates with Measures of Hepatocyte Apoptosis and Fibrosis in NAFLD in Type 2 Diabetes Mellitus and Obesity: A Dual Cohort Cross-Sectional Study. Journal of Diabetes, 7(6), 809-819. [More Information]
  • Williams, K., Vieira de Ribeiro, A., Prakoso, E., Veillard, A., Shackel, N., Bu, Y., Brooks, B., Cavanagh, E., Raleigh, J., McLennan, S., McCaughan, G., Keane, F., Twigg, S., Gorrell, M., et al (2015). Lower serum fibroblast activation protein shows promise in the exclusion of clinically significant liver fibrosis due to non-alcoholic fatty liver disease in diabetes and obesity. Diabetes Research and Clinical Practice, 108(3), 466-472. [More Information]
  • Fuller, N., Caterson, I., Sainsbury, A., Denyer, G., Fong, M., Gerofi, J., Baqleh, K., Williams, K., Lau, N., Markovic, T. (2015). The effect of a high-egg diet on cardiovascular risk factors in people with type 2 diabetes: the Diabetes and Egg (DIABEGG) study-a 3-mo randomized controlled trial. The American Journal of Clinical Nutrition, 101(4), 705-713. [More Information]

2014

  • Fuller, N., Williams, K., Shrestha, R., Ahern, A., Holzapfel, C., Hauner, H., Jebb, S., Caterson, I. (2014). Changes in physical activity during a weight loss intervention and follow-up; a randomized controlled trial. Clinical Obesity, 4(3), 127-135. [More Information]

2013

  • Williams, K., Shackel, N., Gorrell, M., McLennan, S., Twigg, S. (2013). Diabetes and Nonalcoholic Fatty Liver Disease: A Pathogenic Duo. Endocrine Reviews, 34(1), 84-129. [More Information]

To update your profile click here. For support on your academic profile contact .